Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1998 1
1999 2
2000 4
2001 2
2004 2
2006 1
2007 2
2008 2
2010 3
2011 3
2012 2
2013 5
2014 3
2015 3
2016 6
2017 6
2018 4
2019 8
2020 11
2021 21
2022 11
2023 13
2024 9
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Preoperative Chemoradiotherapy for Resectable Gastric Cancer.
Leong T, Smithers BM, Michael M, Haustermans K, Wong R, Gebski V, O'Connell RL, Zalcberg J, Boussioutas A, Findlay M, Willis D, Moore A, Murray WK, Lordick F, O'Callaghan C, Swallow C, Darling G, Miller D, Strickland A, Liberman M, Mineur L, Simes J; Australasian Gastro-Intestinal Trials Group, National Health and Medical Research Council Clinical Trials Centre, Trans-Tasman Radiation Oncology Group, European Organisation for Research and Treatment of Cancer, and Canadian Cancer Trials Group. Leong T, et al. Among authors: o connell rl. N Engl J Med. 2024 Nov 14;391(19):1810-1821. doi: 10.1056/NEJMoa2405195. Epub 2024 Sep 14. N Engl J Med. 2024. PMID: 39282905 Clinical Trial.
TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG.
Leong T, Smithers BM, Haustermans K, Michael M, Gebski V, Miller D, Zalcberg J, Boussioutas A, Findlay M, O'Connell RL, Verghis J, Willis D, Kron T, Crain M, Murray WK, Lordick F, Swallow C, Darling G, Simes J, Wong R. Leong T, et al. Among authors: o connell rl. Ann Surg Oncol. 2017 Aug;24(8):2252-2258. doi: 10.1245/s10434-017-5830-6. Epub 2017 Mar 23. Ann Surg Oncol. 2017. PMID: 28337660 Clinical Trial.
Multi-centre randomised controlled trial comparing arthroscopic hip surgery to physiotherapist-led care for femoroacetabular impingement (FAI) syndrome on hip cartilage metabolism: the Australian FASHIoN trial.
Hunter DJ, Eyles J, Murphy NJ, Spiers L, Burns A, Davidson E, Dickenson E, Fary C, Foster NE, Fripp J, Griffin DR, Hall M, Kim YJ, Linklater JM, Molnar R, Neubert A, O'Connell RL, O'Donnell J, O'Sullivan M, Randhawa S, Reichenbach S, Schmaranzer F, Singh P, Tran P, Wilson D, Zhang H, Bennell KL. Hunter DJ, et al. Among authors: o connell rl. BMC Musculoskelet Disord. 2021 Aug 16;22(1):697. doi: 10.1186/s12891-021-04576-z. BMC Musculoskelet Disord. 2021. PMID: 34399702 Free PMC article. Clinical Trial.
Anatomy relevant to conservative mastectomy.
O'Connell RL, Rusby JE. O'Connell RL, et al. Gland Surg. 2015 Dec;4(6):476-83. doi: 10.3978/j.issn.2227-684X.2015.02.06. Gland Surg. 2015. PMID: 26645002 Free PMC article. Review.
The effect of monthly vitamin D supplementation on fractures: a tertiary outcome from the population-based, double-blind, randomised, placebo-controlled D-Health trial.
Waterhouse M, Ebeling PR, McLeod DSA, English D, Romero BD, Baxter C, Armstrong BK, Hartel G, Kimlin M, O'Connell RL, van der Pols JC, Venn AJ, Webb PM, Whiteman DC, Neale RE. Waterhouse M, et al. Among authors: o connell rl. Lancet Diabetes Endocrinol. 2023 May;11(5):324-332. doi: 10.1016/S2213-8587(23)00063-3. Epub 2023 Mar 31. Lancet Diabetes Endocrinol. 2023. PMID: 37011645 Clinical Trial.
Relationship of haptoglobin phenotype and levels with sight-threatening diabetic retinopathy in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in diabetes (FIELD) substudy.
Ong KL, Januszewski AS, Francis H, O'Connell RL, Mangani A, Li L, Colman PG, Sullivan DR, Scott RS, Jenkins AJ, Keech AC; FIELD Study Investigators. Ong KL, et al. Among authors: o connell rl. Diabetes Res Clin Pract. 2025 Apr;222:112080. doi: 10.1016/j.diabres.2025.112080. Epub 2025 Mar 11. Diabetes Res Clin Pract. 2025. PMID: 40081501 Free article. Clinical Trial.
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.
Lee CK, Kartikasari AER, Bound NT, Francis KE, Shield-Artin K, Bedo J, Nesic K, Diamante K, O'Connell RL, Madondo M, Cox M, Davies C, Deceneux C, Goodchild G, Jarratt A, Cassar E, Amer H, Kariyawasam UGIU, Lee YC, Lombard J, Baron-Hay S, Antill Y, Shannon C, Selva-Nayagam S, Beale P, Zebic D, Simon S, Linaker A, Quinn MA, Papenfuss AT, Wakefield MJ, Vandenberg CJ, Friedlander M, Scott CL, Plebanski M. Lee CK, et al. Among authors: o connell rl. Nat Commun. 2025 Nov 5;16(1):9756. doi: 10.1038/s41467-025-64130-6. Nat Commun. 2025. PMID: 41193417 Free PMC article. Clinical Trial.
120 results